Step #1 (of 5) to get your portfolio ready for the Next Big One–Special Report update
Last night I added Step #1 to my Special Report 5 Is Your Portfolio Ready for the Next Big? The post below is a cut and paste of the material I added to the Special Report. I'm posting it separately here to make it a bit more accessible. In my macro picture, I wrote,...
Selling my Parsley Energy call options out of my Volatility Portfolio
Shares of Permian Basin oil shale producer Parsley Energy (PE) were up 16.45% as of 3 p.m. New York time this afternoon. The company reported second quarter earnings of 32 cents a share (after adjusting for a one-time tax-related gain). Unadjusted earnings came to 41...
Updating First Quantum Minerals in my Volatility Portfolio and making it #3 in my bottom fishing Special Report
First Quantum Minerals (FQVLF) is tricky for bottom fishers. If the challenge with Illumina (ILM), my #2 pick for my 5 Bottom Fishing Picks Special Report, Â is figuring out when the bad news will all be in the stock--hence making it a good buy for bottom fishers, the...
Adding silver to my market hedges: Buying First Majestic Silver for my Jubak Picks and Volatility Portfolios
Way back last Friday, July 19, in my Friday Trick or Trend post on JubakAM.com, I argued for adding silver to a portfolio because 1) it is a good hedge for portfolios in the second half of 2019, and because 2) silver, after lagging gold for the first half of 2019 ,...
Using softness to add more Treasury exposure to Volatility Portfolio
Treasury prices have been a little weak over the last two weeks. As a consequence the Vanguard Intermediate Term Treasury ETF (VGIT) and the Vanguard Short Term Treasury ETF (VGSH), for example, have dropped from highs on June 25 of $66.03 and $60.94, respectively, to...
Sangamo gets RMAT status for its hemophilia gene therapy
On July 5 Sangamo Therapeutics (SGMO) and partner Pfizer (PFE) announced update results of a Phase 1/2 study of Sangamo's SB-525 gene therapy for severe hemophilia A. The companies also announced that the U.S. Food & Drug Administration had granted regenerative...
Bonus Dividend Pick for my Volatility Portfolio–DOW, a cash cow with a 5.5% yield
Today, June 28, I added Corteva (CTVA), one of the three stocks to emerge from the merger, reorganization, and then breakup of Dow and DuPont, to my Volatility Portfolio. Â . On Monday, Â I'll be adding another from that breakup to my Volatility Portfolio. This time...
No. 2 Value Pick Constellation Brands up 4.73% today on earnings
On June 26 I added Constellation Brands (STZ), my No. 2 pick in my 5 Best Value Picks Special Report to my Volatility Portfolio. Today, June 28, Constellation Brands closed 4.73% higher on final first quarter earnings. Revenue grew 2.4% year over year. (The company's...
Adding Corteva, #8 in my 10 Best Picks for the Rest of 2019, to my Volatility Portfolio
Last night I added seed and agricultural chemicals company Corteva (CTVA) to my 10 Best Picks for the Rest of 2019 Special Report. Tomorrow June 28, I'll add it to my Volatility Portfolio. Confusion is your friend when you're looking for a stock that the market has...
Bonus Special Report: 5 Value Stocks in a Market Near All-Time Highs
The Standard & Poor's 500 closed at a new all-time high on June 20 at 2954.18. It's easy in today's market to find stocks trading at astronomical price to earnings ratios. Amazon (AMZN) sell for 79.90 times trailing twelve-month earnings per share. Netflix (NFLX)...
Adding Nektar call options to my Volatility Portfolio–again
Again. I'm adding the January 17, 2020 Call Options with a strike at $35 on Nektar Theraeutics (NKTR) to my Volatility Portfolio on JubakAM.com and JugglingWithKnives.com. (Ticker on these options is NKTR200117C00035000.) The underlying shares closed at $33.70, up...Jim’s Stock Alerts
Download Jim’s eBook for Free
